Elicio Therapeutics (ELTX) Exchange Rate Effect (2020 - 2026)
Elicio Therapeutics posted quarterly Exchange Rate Effect of $5000.0 for Q1 2026, down 83.87% year-on-year from $31000.0 in Q1 2025, and up 105.21% on a QoQ basis from -$96000.0 in Q4 2025.
Elicio Therapeutics (ELTX) has 7 years of Exchange Rate Effect data on file, last reported at $5000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 83.87% year-over-year to $5000.0; the trailing twelve-month figure through Mar 2026 stood at $22000.0 (down 58.49% YoY), and the FY2025 full-year result was $48000.0, up 118.18% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at $5000.0, up from -$96000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $87000.0 in Q2 2022 and bottomed at -$96000.0 in Q4 2025.
- The 5-year median for Exchange Rate Effect is $27000.0 (2024), against an average of $5769.2.
- The widest annual swing landed in 2022, when Exchange Rate Effect slumped 2800.0%; it then soared 1700.0% in 2024.
- A 5-year view of Exchange Rate Effect shows it stood at $87000.0 in 2022, then plunged by 97.7% to $2000.0 in 2023, then surged by 1250.0% to $27000.0 in 2024, then slumped by 455.56% to -$96000.0 in 2025, then soared by 105.21% to $5000.0 in 2026.
- The last three Exchange Rate Effect figures came in at $5000.0 (Q1 2026), -$96000.0 (Q4 2025), and $39000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Elicio Therapeutics | 217.63 Mn | 202.68 Mn | - | 5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,000.00 |
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | -96,000.00 |
| Dec 31, 2025 | -96,000.00 |
| Sep 30, 2025 | 39,000.00 |
| Sep 30, 2025 | 39,000.00 |
| Jun 30, 2025 | 74,000.00 |
| Jun 30, 2025 | 74,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Sep 30, 2024 | 36,000.00 |
| Sep 30, 2024 | 36,000.00 |
| Jun 30, 2024 | -41,000.00 |
| Jun 30, 2024 | -41,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | -81,000.00 |
| Jun 30, 2023 | -81,000.00 |
| Mar 31, 2023 | 79,000.00 |
| Mar 31, 2023 | 79,000.00 |
| Jun 30, 2022 | 87,000.00 |
| Jun 30, 2022 | 87,000.00 |
| Mar 31, 2022 | -87,000.00 |
| Mar 31, 2022 | -87,000.00 |
| Dec 31, 2021 | 14,000.00 |
| Dec 31, 2021 | 14,000.00 |
| Sep 30, 2021 | -16,000.00 |
| Sep 30, 2021 | -16,000.00 |
| Jun 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 8,000.00 |
| Mar 31, 2021 | -3,000.00 |
| Mar 31, 2021 | -3,000.00 |
| Dec 31, 2020 | -287,000.00 |
| Dec 31, 2020 | -287,000.00 |
| Sep 30, 2020 | -204,000.00 |
| Sep 30, 2020 | -204,000.00 |
| Jun 30, 2020 | -186,000.00 |
| Jun 30, 2020 | -186,000.00 |
| Mar 31, 2020 | 233,000.00 |
| Mar 31, 2020 | 233,000.00 |